Jump to content

Kevin Volpp

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 16:59, 27 September 2023 (Removed proxy/dead URL that duplicated identifier. Removed parameters. | Use this bot. Report bugs. | #UCB_CommandLine). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Kevin G. Volpp is an American behavioral economist and Mark V. Pauly President's Distinguished Professor at the University of Pennsylvania’s Perelman School of Medicine and the Wharton School. He is the Director of the Penn Center for Health Incentives & Behavioral Economics (CHIBE).[1].

Education

Volpp earned his bachelor’s degree magna cum laude in biology from Harvard and was a Rotary Scholar at Freie Universitat in Berlin, Germany.[2] He earned an MD from the University of Pennsylvania’s Perelman School of Medicine and a PhD from the Wharton School from the graduate group in Applied Economics and Managerial Science.[2]

Appointments

Volpp is the Division Chief of the Health Policy Division of the Department of Medical Ethics and Health Policy at the Perelman School of Medicine.[3] For 20 years, he also served as an attending physician at the Philadelphia VA Medical Center and worked as a part-time primary care clinician and hospitalist.[4]

Research

Volpp’s research applies principles of behavioral economics to improve health and health care. One study led by Volpp was a large randomized trial of financial incentives and smoking cessation among employees at General Electric.[5] Long-term quit rates from a $750 incentive were approximately three times higher in the intervention group.[5] The main trial paper led GE to implement a benefit design change based on this study to its 150,000 US employees.[6][7] Follow-up work[8] extended this among employees at CVS and also demonstrated a tripling in long-term smoking cessation rates and led to a national program among CVS employees called “700 Good Reasons.”[9] This was followed by a large-scale study of financial incentives and smoking cessation that found that offering standard pharmacologic therapies and e-cigarettes were no more effective than control whereas either gain- or loss-framed incentives tripled smoking cessation rates among employees of 54 different employers[10][11]

His team has also conducted studies examining the impact of behavioral economic strategies on increasing physical activity,[12][13] medication adherence,[14] and on physician behavior.[15][16]

Volpp’s research group also conducted a number of national evaluations of the 2003 and 2011 national duty hour regulations, the first to regulate work hours for physicians in the United States in a series of papers published in JAMA. [17] [18][19]

Awards and honors

2005 Presidential Award for Early Career Scientists and Engineers (PECASE)[20]
2010 British Medical Journal Group Awards for "Translating Research into Practice" for work on financial incentives and smoking cessation implemented by General Electric[7]
2012 Elected to Institute of Medicine (now the National Academy of Medicine)[21]
2015 Matilda White Riley Award for Distinguished Research Contributions from Office of Social and Behavioral Sciences, NIH[4]

Association for Clinical and Translational Science Distinguished Investigator Award for Translation from Clinical Use into Public Benefit and Policy[22]

2019 John Eisenberg Award for Career Achievement in Research, Society of General Internal Medicine[23]
2022 Distinguished Scientist Award from the American Heart Association

References

  1. ^ "The Center for Health Incentives & Behavioral Economics". CHIBE.
  2. ^ a b "Kevin Volpp, MD, PhD". Center for Health Incentives & Behavioral Economics.
  3. ^ "Kevin Volpp". Department of Medical Ethics & Health Policy.
  4. ^ a b "8th Matilda White Riley Honors: 2015". National Institutes of Health Office of Behavioral and Social Services Research. 2015.
  5. ^ a b Volpp, Kevin (February 12, 2009). "A Randomized, Controlled Trial of Financial Incentives for Smoking Cessation". New England Journal of Medicine. 360 (7): 699–709. doi:10.1056/nejmsa0806819. PMID 19213683.
  6. ^ Schilling, Brian. "What Happened When GE Paid Employees to Quit Smoking?". The Commonwealth Fund.
  7. ^ a b "NEJM Paper on Financial Incentives for Smoking Cessation". Penn LDI. 2017.
  8. ^ Halpern, Scott (May 28, 2015). "Randomized Trial of Four Financial-Incentive Programs for Smoking Cessation". New England Journal of Medicine. 372 (22): 2108–2117. doi:10.1056/nejmoa1414293. PMC 4471993. PMID 25970009.
  9. ^ "CVS Health Research Institute Study Finds Smoking Cessation Programs with Financial Incentives Increase Rates of Quitting and Staying Smoke-free". CVS Health. May 13, 2015.
  10. ^ Halpern, Scott (June 14, 2018). "A Pragmatic Trial of E-Cigarettes, Incentives, and Drugs for Smoking Cessation". New England Journal of Medicine. 378 (24): 2302–2310. doi:10.1056/nejmsa1715757. PMID 29791259. S2CID 43934566.
  11. ^ Giordano, Rita (May 24, 2018). "Quitting smoking is incredibly hard. Penn researchers find one thing that helps most". Philadelphia Inquirer.
  12. ^ Patel, Mitesh (November 2017). "Effect of a Game-Based Intervention Designed to Enhance Social Incentives to Increase Physical Activity Among Families". JAMA Internal Medicine. 177 (11): 1586–1593. doi:10.1001/jamainternmed.2017.3458. PMC 5710273. PMID 28973115.
  13. ^ Case, Meredith (February 10, 2015). "Accuracy of Smartphone Applications and Wearable Devices for Tracking Physical Activity Data". JAMA. 313 (6): 625–626. doi:10.1001/jama.2014.17841. PMID 25668268.
  14. ^ Kessler, Judd (March 15, 2018). "Partners and Alerts in Medication Adherence: A Randomized Clinical Trial". Journal of General Internal Medicine. 33 (9): 1536–1542. doi:10.1007/s11606-018-4389-7. PMC 6109000. PMID 29546659.
  15. ^ Navathe, Amol (July 2, 2019). "Association Between the Implementation of a Population-Based Primary Care Payment System and Achievement on Quality Measures in Hawaii". JAMA. 322 (1): 57–68. doi:10.1001/jama.2019.8113. PMC 6613291. PMID 31265101.
  16. ^ Navathe, Amol (March 2022). "The Effect Of Clinician Feedback Interventions On Opioid Prescribing". Health Affairs. 41 (3): 424–433. doi:10.1377/hlthaff.2021.01407. PMID 35254932. S2CID 247295140.
  17. ^ Volpp, Kevin (September 5, 2007). "Mortality Among Hospitalized Medicare Beneficiaries in the First 2 Years Following ACGME Resident Duty Hour Reform". JAMA Network. 298 (9): 975–983. doi:10.1001/jama.298.9.975. PMID 17785642.
  18. ^ Volpp, Kevin (September 5, 2007). "Mortality Among Patients in VA Hospitals in the First 2 Years Following ACGME Resident Duty Hour Reform". JAMA. 298 (9): 984–992. doi:10.1001/jama.298.9.984. PMID 17785643.
  19. ^ Patel, Mitesh (December 10, 2014). "Association of the 2011 ACGME Resident Duty Hour Reforms With Mortality and Readmissions Among Hospitalized Medicare Patients". JAMA. 312 (22): 2364–2373. doi:10.1001/jama.2014.15273. PMC 5546100. PMID 25490327.
  20. ^ "News and Policies: June 2005". The White House. June 2005. Archived from the original on 2021-06-21. Retrieved 2022-04-06.
  21. ^ "Kevin Volpp, M.D., Ph.D. Elected to Institute of Medicine". Health Services Research & Development - Veterans Affairs. October 16, 2012.
  22. ^ "Penn Medicine Researcher Receives Distinguished Investigator Award". Penn Today. May 19, 2015.
  23. ^ Levins, Hoag (May 13, 2019). "Penn Medicine's Volpp, Venkataramani and Kangovi Win SGIM Awards". Penn LDI.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Kevin_Volpp&oldid=1177451793"